Rheumatologic Disorders

Disease State Hub

FDA Alerts

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

Rheumatologic disorders

FDA Approves New Biosimilar

10/31/2018

Rheumatologic disorders

FDA Approves Biosimilar to Humira

08/28/2017

The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.

08/28/2017

Research Summaries

Research Summary

Global Disease Burden of Osteoarthritis Across Two Decades and Future Projections

01/10/2024

Jessica Ganga

Osteoarthritis is a common chronic and degenerative disease among adults. A group of experts estimated the disease’s burden spanning two decades and the projection of burden to 2050.

01/10/2024

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

research summary

research summary

Drug Survival, Effectiveness of IL-23 Inhibitors for Psoriasis, PsA

10/26/2023

Leigh Precopio

Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...

10/26/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

Research Summary

Treatment of Psoriatic Arthritis in Pregnant Women Increases Risks

04/28/2023

Jessica Ganga

The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.

04/28/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4